{
  "run_id": "RUN_20260203_072040_a0aea931a61c",
  "timestamp": "2026-02-03T09:00:08.795809",
  "document": "Fetal-Hydantoin-Syndrome.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/dev/Fetal-Hydantoin-Syndrome.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 3,
  "total_validated": 3,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "Fetal hydantoin syndrome",
      "preferred_label": "fetal hydantoin syndrome",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0060690",
        "orpha": null,
        "umls": "UMLS:C0149969",
        "mesh": "C537922"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0060690",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:101775",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:617955",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0149969",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C537922",
          "display": "Fetal hydantoin syndrome"
        }
      ],
      "context": "Fetal hydantoin syndrome affects males and females in equal numbers. The exact incidence and prevalence of the disorder is unknown. Studies have suggested that approximately 5%-10% of infants exposed to phenytoin during pregnancy will develop fetal hydantoin syndrome. There is no diagnostic testing that can identify fetal",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "Fetal hydantoin syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "disorder",
      "preferred_label": "disease",
      "abbreviation": null,
      "confidence": 0.65,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0000001",
        "orpha": "Orphanet:377788",
        "umls": "UMLS:C0012634",
        "mesh": "MESH:D004194"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0000001",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:4",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:799.9",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:4347",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D004194",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2991",
          "display": null
        },
        {
          "system": "OGMS",
          "code": "OGMS:0000031",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:377788",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:64572001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0012634",
          "display": null
        }
      ],
      "context": "Fetal hydantoin syndrome affects males and females in equal numbers. The exact incidence and prevalence of the disorder is unknown. Studies have suggested that approximately 5%-10% of infants exposed to phenytoin during pregnancy will develop fetal hydantoin syndrome. There is no diagnostic testing that can identify fetal hydantoin syndrome. A diagnosis is made clinically based upon identification of characteristic",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Mental Disorders",
        "Cardiovascular Diseases",
        "COVID-19"
      ],
      "pubtator_normalized_name": "Disease",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "can",
      "preferred_label": "CAN",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0012833",
        "orpha": "Orphanet:93262",
        "umls": "UMLS:C2677099",
        "mesh": "MESH:C567382"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0012833",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0111161",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:16810",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:394201",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:C567382",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C38145",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:612247",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:93262",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:702361006",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C2677099",
          "display": null
        }
      ],
      "context": "hydantoin syndrome affects males and females in equal numbers. The exact incidence and prevalence of the disorder is unknown. Studies have suggested that approximately 5%-10% of infants exposed to phenytoin during pregnancy will develop fetal hydantoin syndrome. There is no diagnostic testing that can identify fetal hydantoin syndrome. A diagnosis is made clinically based upon identification of characteristic symptoms in an affected infant in conjunction with a history of phenytoin exposure during gestation. It is important to note that the majority of infants born to women who take phenytoin du",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Breast Neoplasms",
        "Cancer Pain",
        "Colorectal Neoplasms"
      ],
      "pubtator_normalized_name": "Neoplasms",
      "enrichment_source": "pubtator3"
    }
  ]
}